| Literature DB >> 28574793 |
Maciej Daniszewski1,2, Duncan E Crombie1,2, Rachael Henderson1,2, Helena H Liang1,2, Raymond C B Wong1,2, Alex W Hewitt1,2,3, Alice Pébay1,2.
Abstract
Pluripotent stem cells are an extremely powerful tool in modeling human diseases and hold much promise for personalized regenerative or cell replacement therapies. There is an increasing need for reproducible large-scale stem cell and differentiated progeny production, with minimal variation, rendering manual approaches impracticable. Here, we provide an overview of systems currently available for automated stem cell culture, and undertake a review of their capacities, capabilities, and relative limitations. With the merging of modern technology and stem cell biology, an increased demand and implementation of automated platforms for stem cell studies is anticipated.Entities:
Keywords: automated stem cell system; automation; differentiation; embryonic stem cells; induced pluripotent stem cells; passaging
Mesh:
Year: 2017 PMID: 28574793 DOI: 10.1177/2472630317712220
Source DB: PubMed Journal: SLAS Technol ISSN: 2472-6303 Impact factor: 3.047